Davis's Drug Guide
sirolimus (topical)
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
sir-oh-li-mus
Trade Name(s)
- Hyftor
Ther. Class.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Sirolimus (topical)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580084/all/sirolimus__topical_.
Vallerand AHA, Sanoski CAC, . Sirolimus (topical). Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580084/all/sirolimus__topical_. Accessed April 22, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Sirolimus (topical). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580084/all/sirolimus__topical_
Vallerand AHA, Sanoski CAC, . Sirolimus (topical) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 22]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580084/all/sirolimus__topical_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - sirolimus (topical)
ID - 3580084
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580084/all/sirolimus__topical_
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
